The global high-throughput screening market is anticipated to grow at a considerable CAGR of 7.7% during the forecast period. The key factors that are contributing to the market growth are increasing investments, and funding activities by government, regulatory bodies, research institutes, and companies, owing to which the adoption of products, services, and technologies in various applications are driving market growth further. For instance,
Browse the full report description of “High-Throughput Screening Market Size, Share & Trends Analysis Report by Product and Services (Consumables, Instruments, Services, and Software), by Technology (Cell-Based Assays, Lab-on-a-Chip Technology, and Label-Free Technology), and by Application (Drug Discovery, Biochemical Screening, Life Sciences Research, and Other) Forecast Period (2022-2028)” at https://www.omrglobal.com/industry-reports/high-throughput-screening-market
• In August 2022, Arch Venture invested $50 million, in a new class of medicines, in the AI-enabled Vilya that could render high-throughput screening obsolete. This new AI-enabled Vilya can transform drug discovery and development, by potentially rendering high throughput screening and it is developed to expand the chemical space and change how drugs are discovered.
• In June 2022, Orbit Discovery Ltd. has been awarded a Smart grant by Innovate UK, of $54 million, for the implementation of cell-based functional screening and to expand the capabilities and throughput of Orbit’s peptide display platform.
• In December 2020, Sygnature Discovery invested £3 million to strengthen its high-throughput screening (HTS) and translational oncology service offerings. This investment is established to support ex-vivo tumor analysis and provide a more comprehensive and integrated service offering to customers.
Market Coverage
• The market number available for – 2021-2028
• Base year- 2021
• Forecast period- 2022-2028
• Segment Covered-
o By Product and Services
o By Technology
o By Application
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- Agilent Technologies, Inc., Charles River Laboratories International Inc, Corning Inc., Danaher Corp., Lonza Group Ltd., Merck KGaA, PerkinElmer Inc., Thermo Fisher Scientific, and others.
Key questions addressed by the report
• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?
Global High-Throughput Screening Market Report Segment
By Product and Services
• Consumables
o Reagents and Assay Kits
o Laboratory Equipment
• Instruments
o Liquid Handling Systems
o Detection Systems
o Other Instruments
• Services
• Software
By Technology
• Cell-Based Assays
o 2D Cell Culture
o 3D Cell Culture
o Reporter-Based Assay
o Perfusion Cell Culture
• Lab-on-a-Chip Technology
• Label-Free Technology
By Application
Global High-Throughput Screening Market Report by Region
North America
• US
• Canada
Europe
• UK
• Germany
• Italy
• Spain
• France
• Rest of Europe
Asia-Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
Rest of the World
• Latin America
• Middle East & Africa
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/high-throughput-screening-market